Aligned Genetics, Inc. (KOSDAQ:238120)

Aligned Genetics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	60,943	54,406	43,496	57,947	54,137	61,614
Market Cap Growth	45.40%	25.08%	-24.94%	7.04%	-12.13%	-13.43%
Enterprise Value	60,830	41,561	31,551	48,198	44,338	52,552
Last Close Price	4335.00	3870.00	3025.00	4030.00	3765.00	4285.00
PE Ratio	21.04	18.69	10.54	17.91	23.21	11.12
PS Ratio	3.81	3.40	2.76	3.81	3.94	5.24
PB Ratio	1.64	1.46	1.23	1.85	1.88	2.28
P/TBV Ratio	1.65	1.47	1.23	1.85	1.88	2.29
P/FCF Ratio	-	-	15.49	29.41	244.98	-
P/OCF Ratio	16.90	15.09	14.19	20.34	24.36	453.15
EV/Sales Ratio	3.80	2.60	2.00	3.17	3.22	4.47
EV/EBITDA Ratio	19.93	13.62	9.40	12.15	12.67	19.34
EV/EBIT Ratio	24.90	17.01	11.35	14.44	15.56	24.12
EV/FCF Ratio	-8.15	-	11.24	24.47	200.64	-
Debt / Equity Ratio	0.39	0.39	0.08	0.15	0.15	0.16
Debt / EBITDA Ratio	4.75	4.75	0.88	1.18	1.25	1.63
Debt / FCF Ratio	-	-	1.06	2.37	19.82	-
Net Debt / Equity Ratio	0.00	0.00	-0.41	-0.33	-0.32	-0.32
Net Debt / EBITDA Ratio	-0.04	-0.04	-4.37	-2.59	-2.66	-3.20
Net Debt / FCF Ratio	0.02	0.02	-5.23	-5.21	-42.16	2.74
Asset Turnover	0.31	0.31	0.37	0.39	0.39	0.39
Inventory Turnover	1.04	1.04	1.15	1.20	1.64	1.98
Quick Ratio	3.93	3.93	10.86	3.37	11.38	10.98
Current Ratio	5.08	5.08	13.49	4.12	14.67	12.97
Return on Equity (ROE)	8.01%	8.01%	12.36%	10.76%	8.36%	22.87%
Return on Assets (ROA)	2.99%	2.99%	4.08%	5.36%	4.99%	4.54%
Return on Invested Capital (ROIC)	8.18%	8.44%	12.07%	15.54%	14.39%	15.16%
Return on Capital Employed (ROCE)	4.60%	4.60%	6.60%	9.30%	8.00%	6.60%
Earnings Yield	4.78%	5.35%	9.49%	5.58%	4.31%	8.99%
FCF Yield	-12.24%	-13.71%	6.46%	3.40%	0.41%	-5.15%
Buyback Yield / Dilution	1.74%	1.74%	-0.03%	-	-	-38.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.